DailyIQ
Last updated Updating…

SCHD·Schwab U.S. Dividend Equity ETF

Updating price...
Pre-Market
High
$35.22
Open
$35.20
Market Cap
-
52W High
Low
$35.16
P. Close
$35.11
P/E
-
52W Low
Technical Score (1D)
91
BUY
News Sentiment
57
BULLISH

What's happening to SCHD today?

SCHD’s sector tilt is currently being reshaped by a surge in AI‑related demand that is lifting the valuation of its top analog‑chip holdings, most notably Texas Instruments (TXN). Three hours ago, TXN’s fair‑value estimate jumped to $324 from $298, prompting analysts to lift price targets into the $340–$400 range as the company’s capacity expansion and strong Q2 earnings (up 23% YoY) underpin expectations of sustained AI‑chip growth. This upgrade signals that the ETF’s exposure to the semiconductor space could see a modest upside over the next 1–10 trading days as investors chase the AI tailwind. Five hours ago, Costco Wholesale (COST) announced a partnership with SCAN Group to launch Medicare Advantage plans, diversifying its revenue base beyond retail and adding a recurring income stream that could cushion the ETF’s consumer‑goods exposure. The rollout’s progress and enrollment figures will be key to assessing whether this healthcare push materially alters COST’s earnings trajectory. Broadcom (AVGO) has been in the news for a potential $60‑billion debt package aimed at financing AI chip production for partners such as Anthropic, a move that could expand its high‑margin AI hardware business and improve cash flow. The financing aligns with a broader semiconductor trend of leveraging debt to accelerate AI infrastructure, and traders should watch the final terms and lender composition for any impact on AVGO’s balance sheet and future capital‑expenditure plans. The combination of TXN’s AI‑chip upside, COST’s new Medicare revenue stream, and AVGO’s aggressive AI financing creates a cross‑holding narrative of rising demand for AI infrastructure and diversification into stable, recurring income sources. Over the next ten days, SCHD’s sector exposure will likely benefit from continued AI tailwinds in the semiconductor space while gaining resilience from COST’s healthcare expansion. Traders should monitor the upcoming earnings guidance for TXN and AVGO, the enrollment pace of COST’s Medicare plans, and any regulatory updates that could affect AVGO’s large debt package.